Wayne, PA, May 7, 2024 (Business Wire) -- Brian Walsh, previously at Carl Zeiss, has been appointed as the new Chief Executive Officer at Cagent Vascular. His extensive experience in the medical device and healthcare industry positions him well to drive Cagent Vascular’s flagship product, Serranator.
Read full article here.
Palo Alto, CA, May 2, 2024 (Globe Newswire) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) recently completed a $200M private financing round for its former subsidiary, TheRas, Inc. d/b/a BridgeBio Oncolo
San Diego, CA, May 2, 2024 (QuidelOrtho) -- Brian J. Blaser has been appointed as the new President and CEO of QuidelOrtho. Most recently overseeing Abbott's global diagnostics organization, he brin
Watertown, MA, May 2, 2024 (finance.yahoo.com) -- Novartis is acquiring Mariana Oncology, a biotech firm specializing in targeted radiation medicines, for $1 billion. Mariana could receive up to $75
